Jecko Thachil: Interrupting Antiplatelet Therapy for Urgent and Planned Surgery
Jecko Thachil, MAHSC Professor, at the University of Manchester, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Cardiovascular and cerebrovascular diseases are major causes of morbidity and morality in the world. Antiplatetelet therapies play a major role in the management of these conditions.
But when a patient receiving antiplatelet medications requires urgent or planned surgery, how do we deal with interrupting these treatments? Discussed in the following review.”
Title: How to undertake procedures while on antiplatelet agents: a hematologist’s view
Authors: Dawn Swan, Robert Turner, James Douketis, Jecko Thachil
Read the Full Article on RPTH.
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit